AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
1-HYDROXYLATION AND 3-HYDROXYLATION, IN ADDITION TO 4-HYDROXYLATION, OF DEBRISOQUINE ARE CATALYZED BY CYTOCHROME-P450 2D6 IN HUMANS
Authors: EIERMANN B EDLUND PO TJERNBERG A DALEN P DAHL ML BERTILSSON L
Citation: B. Eiermann et al., 1-HYDROXYLATION AND 3-HYDROXYLATION, IN ADDITION TO 4-HYDROXYLATION, OF DEBRISOQUINE ARE CATALYZED BY CYTOCHROME-P450 2D6 IN HUMANS, Drug metabolism and disposition, 26(11), 1998, pp. 1096-1101
ANTIBIOTIC USE IN 3 EUROPEAN UNIVERSITY HOSPITALS
Authors: KIIVET RA DAHL ML LLERENA A MAIMETS M WETTERMARK B BERECZ R
Citation: Ra. Kiivet et al., ANTIBIOTIC USE IN 3 EUROPEAN UNIVERSITY HOSPITALS, Scandinavian journal of infectious diseases, 30(3), 1998, pp. 277-280
CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M SEENSALU R TYBRING G DAHL ML BERTILSSON L
Citation: M. Sagar et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1034-1038
CYP2D6 AND CYP2C19 GENOTYPES IN AN ELDERLY SWEDISH POPULATION
Authors: YAMADA H DAHL ML LANNFELT L VIITANEN M WINBLAD B SJOQVIST F
Citation: H. Yamada et al., CYP2D6 AND CYP2C19 GENOTYPES IN AN ELDERLY SWEDISH POPULATION, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 479-481
THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE
Authors: SAGAR M TYBRING G DAHL ML BERTILSSON L SEENSALU R
Citation: M. Sagar et al., THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE, Gastroenterology, 114(4), 1998, pp. 1122-1122
GENOTYPING OF HUMAN CYTOCHROME-P450 2A6 (CYP2A6), A NICOTINE C-OXIDASE
Authors: OSCARSON M GULLSTEN H RAUTIO A BERNAL ML SINUES B DAHL ML STENGARD JH PELKONEN O RAUNIO H INGELMANSUNDBERG M
Citation: M. Oscarson et al., GENOTYPING OF HUMAN CYTOCHROME-P450 2A6 (CYP2A6), A NICOTINE C-OXIDASE, FEBS letters, 438(3), 1998, pp. 201-205
PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES
Authors: YUE QY ZHONG ZH TYBRING G DALEN P DAHL ML BERTILSSON L SJOQVIST F
Citation: Qy. Yue et al., PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 384-390
BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE
Authors: HERRLIN K MASSELE AY JANDE M ALM C TYBRING G ABDI YA WENNERHOLM A JOHANSSON I DAHL ML BERTILSSON L GUSTAFSSON LL
Citation: K. Herrlin et al., BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 391-401
CYP2D6 POLYMORPHISM IS NOT CRUCIAL FOR THE DISPOSITION OF SELEGILINE
Authors: SCHEININ H ANTTILA M DAHL ML KARNANI H NYMAN L TAAVITSAINEN P PELKONEN O BERTILSSON L
Citation: H. Scheinin et al., CYP2D6 POLYMORPHISM IS NOT CRUCIAL FOR THE DISPOSITION OF SELEGILINE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 402-411
10-HYDROXYLATION OF NORTRIPTYLINE IN WHITE PERSONS WITH 0-FUNCTIONAL,1-FUNCTIONAL, 2-FUNCTIONAL, 3-FUNCTIONAL, AND 13-FUNCTIONAL C-UPSILON-P2D6 GENES
Authors: DALEN P DAHL ML RUIZ MLB NORDIN J BERTILSSON L
Citation: P. Dalen et al., 10-HYDROXYLATION OF NORTRIPTYLINE IN WHITE PERSONS WITH 0-FUNCTIONAL,1-FUNCTIONAL, 2-FUNCTIONAL, 3-FUNCTIONAL, AND 13-FUNCTIONAL C-UPSILON-P2D6 GENES, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 444-452
IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS
Authors: DAHL ML VOORTMAN G ALM C ELWIN CE DELBRESSINE L VOS R BOGAARDS JJP BERTILSSON L
Citation: Ml. Dahl et al., IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS, Clinical drug investigation, 13(1), 1997, pp. 37-46
CITALOPRAM CAUSES NO SIGNIFICANT ALTERATIONS IN PLASMA NEUROLEPTIC LEVELS IN SCHIZOPHRENIC-PATIENTS
Authors: SYVALAHTI EKG TAIMINEN T SAARIJARVI S LEHTO H NIEMI H AHOLA V DAHL ML SALOKANGAS RKR
Citation: Ekg. Syvalahti et al., CITALOPRAM CAUSES NO SIGNIFICANT ALTERATIONS IN PLASMA NEUROLEPTIC LEVELS IN SCHIZOPHRENIC-PATIENTS, Journal of international medical research, 25(1), 1997, pp. 24-32
THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS
Authors: MIHARA K OTANI K TYBRING G DAHL ML BERTILSSON L KANEKO S
Citation: K. Mihara et al., THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS, Journal of clinical psychopharmacology, 17(6), 1997, pp. 467-471
QUICK ONSET OF SEVERE ABDOMINAL-PAIN AFTER CODEINE IN AN ULTRARAPID METABOLIZER OF DEBRISOQUINE
Authors: DALEN P FRENGELL C DAHL ML SJOQVIST F
Citation: P. Dalen et al., QUICK ONSET OF SEVERE ABDOMINAL-PAIN AFTER CODEINE IN AN ULTRARAPID METABOLIZER OF DEBRISOQUINE, Therapeutic drug monitoring, 19(5), 1997, pp. 543-544
IS THE CHOLESTEROL-LOWERING EFFECT OF SIMVASTATIN INFLUENCED BY CYP2D6 POLYMORPHISM
Authors: NORDIN C DAHL ML ERIKSSON M SJOBERG S
Citation: C. Nordin et al., IS THE CHOLESTEROL-LOWERING EFFECT OF SIMVASTATIN INFLUENCED BY CYP2D6 POLYMORPHISM, Lancet, 350(9070), 1997, pp. 29-30
DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS IN A RUSSIAN POPULATION LIVING IN ESTONIA
Authors: MARANDI T DAHL ML RAGO L KIIVET R SJOQVIST F
Citation: T. Marandi et al., DEBRISOQUINE AND S-MEPHENYTOIN HYDROXYLATION POLYMORPHISMS IN A RUSSIAN POPULATION LIVING IN ESTONIA, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 257-260
GENETIC-POLYMORPHISM OF HUMAN CYP2E1 - CHARACTERIZATION OF 2 VARIANT ALLELES
Authors: HU Y OSCARSON M JOHANSSON I YUE QY DAHL ML TABONE M ARINCO S ALBANO E INGELMANSUNDBERG M
Citation: Y. Hu et al., GENETIC-POLYMORPHISM OF HUMAN CYP2E1 - CHARACTERIZATION OF 2 VARIANT ALLELES, Molecular pharmacology, 51(3), 1997, pp. 370-376
INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M BERTILSSON L DAHL ML TYBRING G SEENSALU R
Citation: M. Sagar et al., INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 275-275
PAROXETINE WITHDRAWAL SYNDROME IN A NEONATE
Authors: DAHL ML OLHAGER E AHLNER J
Citation: Ml. Dahl et al., PAROXETINE WITHDRAWAL SYNDROME IN A NEONATE, British Journal of Psychiatry, 171, 1997, pp. 391-392
TRAFFIC DANGEROUS DRUGS ARE OFTEN FOUND IN FATALLY INJURED OLDER MALEDRIVERS
Authors: JOHANSSON K BRYDING G DAHL ML HOLMGREN P VIITANEN M
Citation: K. Johansson et al., TRAFFIC DANGEROUS DRUGS ARE OFTEN FOUND IN FATALLY INJURED OLDER MALEDRIVERS, Journal of the American Geriatrics Society, 45(8), 1997, pp. 1029-1031
SEIZURES AND MYOCLONUS ASSOCIATED WITH ANTIDEPRESSANT TREATMENT - ASSESSMENT OF POTENTIAL RISK-FACTORS, INCLUDING CYP2D6 AND CYP2C19 POLYMORPHISMS, AND TREATMENT WITH CYP2D6 INHIBITORS
Authors: SPIGSET O HEDENMALM K DAHL ML WIHOLM BE DAHLQVIST R
Citation: O. Spigset et al., SEIZURES AND MYOCLONUS ASSOCIATED WITH ANTIDEPRESSANT TREATMENT - ASSESSMENT OF POTENTIAL RISK-FACTORS, INCLUDING CYP2D6 AND CYP2C19 POLYMORPHISMS, AND TREATMENT WITH CYP2D6 INHIBITORS, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 379-384
PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS
Authors: BERTILSSON L DAHL ML TYBRING G
Citation: L. Bertilsson et al., PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS, Acta psychiatrica Scandinavica, 96, 1997, pp. 14-21
STEADY-STATE PLASMA-LEVELS OF NORTRIPTYLINE AND ITS 1.0-HYDROXY METABOLITE - RELATIONSHIP TO THE CYP2D6 GENOTYPE
Authors: DAHL ML BERTILSSON L NORDIN C
Citation: Ml. Dahl et al., STEADY-STATE PLASMA-LEVELS OF NORTRIPTYLINE AND ITS 1.0-HYDROXY METABOLITE - RELATIONSHIP TO THE CYP2D6 GENOTYPE, Psychopharmacology, 123(4), 1996, pp. 315-319
POLYMORPHIC DRUG OXIDATION - RELEVANCE TO THE TREATMENT OF PSYCHIATRIC-DISORDERS
Authors: BERTILSSON L DAHL ML
Citation: L. Bertilsson et Ml. Dahl, POLYMORPHIC DRUG OXIDATION - RELEVANCE TO THE TREATMENT OF PSYCHIATRIC-DISORDERS, CNS DRUGS, 5(3), 1996, pp. 200-223
CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED BY OMEPRAZOLE IN A KOREAN POPULATION
Authors: ROH HK DAHL ML TYBRING G YAMADA H CHA YN BERTILSSON L
Citation: Hk. Roh et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED BY OMEPRAZOLE IN A KOREAN POPULATION, Pharmacogenetics, 6(6), 1996, pp. 547-551
Risultati: 1-25 | 26-50 | 51-53